Eiko Lifescience

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE666Q01016
  • NSEID:
  • BSEID: 540204
INR
50.18
0.24 (0.48%)
BSENSE

May 08

BSE+NSE Vol: 10.03 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002696,
    "name": "Eiko Lifescience",
    "stock_name": "Eiko Lifescience",
    "full_name": "Eiko Lifesciences Ltd",
    "name_url": "stocks-analysis/eiko-lifescience",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "50.18",
    "chg": 0.24,
    "chgp": "0.48%",
    "dir": 1,
    "prev_price": "49.94",
    "mcapval": "72.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540204,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 5,
    "indexname": "India SENSEX",
    "isin": "INE666Q01016",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "10.03 k",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/eiko-lifescience-1002696-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-3973255",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EikoLifescience_mojoScore_3973255.png",
        "date": "2026-05-04 10:10:03",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-3955910",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EikoLifescience_mojoScore_3955910.png",
        "date": "2026-04-21 10:10:03",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 April 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-3941598",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EikoLifescience_mojoScore_3941598.png",
        "date": "2026-04-10 10:10:03",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd Falls to 52-Week Low of Rs 45.9 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eiko-lifesciences-ltd-stock-hits-52-week-low-at-rs459-3925321",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EikoLifescience_priceRelatedfactors_3925321.png",
        "date": "2026-03-30 14:27:25",
        "description": "A 30.3% decline from its 52-week high of Rs 65.9 has dragged Eiko Lifesciences Ltd to a fresh 52-week low of Rs 45.9 on 30 Mar 2026, marking a notable downturn despite recent positive earnings trends."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-3923881",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EikoLifescience_mojoScore_3923881.png",
        "date": "2026-03-30 10:10:02",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-3893350",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EikoLifescience_mojoScore_3893350.png",
        "date": "2026-03-16 10:10:02",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with the most up-to-date insight into the company's performance and outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-by-marketsmojo-3869040",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EikoLifescience_mojoScore_3869040.png",
        "date": "2026-03-04 10:10:02",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-3842357",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/EikoLifescience_mojoScore_3842357.png",
        "date": "2026-02-16 10:10:04",
        "description": "Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 484,
    "sid": "1002696",
    "stock_news_url": "https://www.marketsmojo.com/news/eiko-lifesciences-1002696"
  },
  "announcements": [
    {
      "caption": "Non Applicability Of Annual Disclosure As Per SEBI Circular - Fund Raising By Issuance Of Debt Securities By Large Corporates.",
      "datetime": "09-Apr-2026",
      "details": "In view of SEBI circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November 2018 and amendments thereto (the said Circular) we wish to inform you that as on 31st March 2026 Eiko Lifesciences Ltd. is not a Large Corporate in terms of the criteria specified under the said SEBI Circular. In view of this the framework for fund raising by issuance of Debt Securities by Large Corporate is not applicable to Eiko Lifesciences Ltd. and the requirement of filing the initial disclosure and annual disclosure does not arise.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter and year ended on 31st March 2026 received from M/s. Bigshare Services Pvt. Ltd. Registrar and Share Transfer Agent of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 as amended and as per Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders (Code) the trading window for dealing in the securities of the Company shall remain closed for designated persons and their immediate relatives from Wednesday 01st April 2026 till 48 hours after the date of Board Meeting wherein inter-alia the approval of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March 2026 would be considered by the Board.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Eiko Lifesciences Ltd has declared <strong>2%</strong> dividend, ex-date: 20 Sep 17",
          "dt": "2017-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Eiko Lifesciences Ltd has announced <strong>2:3</strong> rights issue, ex-date: 07 Jul 23",
          "dt": "2023-07-07",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Non Applicability Of Annual Disclosure As Per SEBI Circular - Fund Raising By Issuance Of Debt Securities By Large Corporates.

09-Apr-2026 | Source : BSE

In view of SEBI circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November 2018 and amendments thereto (the said Circular) we wish to inform you that as on 31st March 2026 Eiko Lifesciences Ltd. is not a Large Corporate in terms of the criteria specified under the said SEBI Circular. In view of this the framework for fund raising by issuance of Debt Securities by Large Corporate is not applicable to Eiko Lifesciences Ltd. and the requirement of filing the initial disclosure and annual disclosure does not arise.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

08-Apr-2026 | Source : BSE

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter and year ended on 31st March 2026 received from M/s. Bigshare Services Pvt. Ltd. Registrar and Share Transfer Agent of the Company.

Closure of Trading Window

25-Mar-2026 | Source : BSE

Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 as amended and as per Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders (Code) the trading window for dealing in the securities of the Company shall remain closed for designated persons and their immediate relatives from Wednesday 01st April 2026 till 48 hours after the date of Board Meeting wherein inter-alia the approval of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March 2026 would be considered by the Board.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Eiko Lifesciences Ltd has declared 2% dividend, ex-date: 20 Sep 17

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Eiko Lifesciences Ltd has announced 2:3 rights issue, ex-date: 07 Jul 23